| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President, CEO and Chair | President & CEO
1 company
Curt R Hartman last filed a Form 4 in November 2024, as President and CEO at CNMD. From January 2015 to November 2024, the filings on record show 3 open-market purchases and 9 sales.
Our model assigns Curt R Hartman a middling insider score of 66/100, based on 7 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +19.3%.
At the last filing, the largest reported position was 9,996 shares of CNMD. The CNMD filings lean toward selling, a net 79,847 shares.
Shares as reported in the last Form 4 for each company; the most recent is from November 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2016 | CNMD Conmed Corp | President & CEO | Buy | 5,000 | $36.32 | $181,621.00 | +22.2% | |
| Aug 6, 2015 | CNMD Conmed Corp | President & CEO | Buy | 2,000 | $55.93 | $111,852.00 | +9.7% |